Click Here To Register

Join us on Tuesday, December 17th, for a live webinar featuring expert insights on optimizing Cell Line Development (CLD) to accelerate biologics development and improve success rates. Hosted by Biospring Partners’ Socs Zacharias, this event will focus on strategies and technologies to overcome common CLD challenges, ensuring faster and more efficient development timelines.

Abzena’s industry leaders Dr. Campbell Bunce, Chief Scientific Officer, and Brett Verstak, Director of Cell Line Development, and ProteoNic’s VP of Business Development, Jonathan Frampton, to discuss the critical role of robust CLD strategies and advanced technology platforms. Learn how innovations like AbZelectPRO™, which integrates Abzena’s CHO-K1 cell line with ProteoNic’s 2G UNic® vector technology, can enhance productivity, reduce risks, and accelerate the generation of IND-enabling data.

Why Attend?

Gain actionable insights into integrating innovative CLD technologies, de-risking strategies, and efficient development approaches to maximize the success of your biologics program.

Register Now